Indiana’s premier drug development and manufacturing sector adds another company to its ecosystem
INCOG BioPharma Services, Inc. announced plans to build new facility in Fishers, Ind., add 150 new jobs
INDIANAPOLIS (Oct. 15, 2020) – Indiana is one of the premier contract drug development and manufacturing centers in the United States. These pharmaceutical contract service providers support the growing outsourcing needs of both large pharmaceutical and smaller biotechnology companies. Nearly 40 contract research and manufacturing organizations employ more than 7,000 workers throughout the state. Companies like Covance Central Labs (Indianapolis), Catalent Biologics (Bloomington) and B2S Life Sciences (Franklin) provide pre-clinical testing, toxicology, product manufacturing and other support to pharmaceutical companies worldwide. Pharmaceutical and biotechnology companies would not be able to discover, develop and distribute their products without these important partners.
This week, INCOG BioPharma announced that they are forming a new biopharmaceutical manufacturing company in Fishers, Ind. Formed by an experienced management team, INCOG BioPharma will construct a new facility and partner with global biopharma companies to help them manufacture their products. INCOG BioPharma plans to hire more than 150 employees and will become another important company within Indiana’s life sciences ecosystem.
Additional information on Indiana’s contract drug development industry can be found at BioCrossroadsLINX.
BioCrossroads (www.biocrossroads.com) is Indiana’s initiative to grow, advance and invest in
the life sciences, a public-private collaboration that supports the region’s existing research and corporate strengths while encouraging new business development. BioCrossroads invests capital and provides support to life sciences businesses, launches new life sciences enterprises (Indiana Biosciences Research Institute, 16 Tech, Indiana Health Information Exchange, Fairbanks Institute for Healthy Communities, BioCrossroadsLINX, OrthoWorx and Datalys Center), expands collaboration and partnerships among Indiana’s life science institutions, promotes science education and markets Indiana’s life sciences industry.
About INCOG BioPharma Services Inc.
Founded in June 2020, INCOG BioPharma will offer development and manufacturing services to both early phase and late phase biopharmaceutical companies—with specific services to include formulation development, analytical method development, process scale up, formulation/filling of biopharmaceuticals into vials, syringes and cartridges, and an integrated solution of specialized packaging services to include labeling, device assembly, final packaging and integrated storage solutions at various temperature conditions. For more information about INCOG BioPharma, visit www.incogbiopharma.com.